MARKET PULSE- Citigroup, Savient Pharma, Mac-Gray, Charles Schwab, Insmed

Tue Oct 15, 2013 11:50am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stocks fell on Tuesday after a four-session rally as Citigroup reported weaker-than-expected quarterly earnings, overshadowing developments in the Washington budget and debt-limit talks.

The Dow Jones industrial average was down 0.16 percent. The Standard & Poor's 500 Index was down 0.11 percent while the Nasdaq Composite Index was up 0.09 percent.

** CITIGROUP INC, $49.19, down 1 pct (9:33 a.m. ET)

The company reported a marginal fall in adjusted quarterly profit from ongoing businesses after the Federal Reserve's decision to continue its bond-buying program for longer than expected slowed trading by clients.

** SAVIENT PHARMACEUTICALS INC, $0.10, down 83 pct (9:34 a.m. ET)   Continued...